Keol-C

Oxygen, the active ingredient in Keol-C, is a medical gas presented as an inhalation gas for respiratory therapy use. It is employed to treat hypoxemia, respiratory distress, COPD exacerbations and postoperative oxygen needs in patients requiring supplemental oxygen.

GNH USA supplies Keol-C as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides regulatory‑approved product documentation for global distribution.

Keol-C (oxygen) is used in respiratory therapy to address conditions associated with low blood oxygen levels.

Hypoxemia: Increases arterial oxygen tension to correct low blood oxygen levels. Respiratory distress: Provides immediate supplemental oxygen to relieve breathing difficulty. COPD exacerbations: Improves oxygenation during acute worsening of chronic obstructive pulmonary disease. Postoperative oxygen therapy: Supports recovery by maintaining adequate oxygen saturation after surgery.

Common Side Effects: - Nasal dryness or irritation - Throat discomfort - Headache - Dizziness - Cough - Fatigue

Serious or Rare Side Effects: - Oxygen toxicity leading to pulmonary injury - Seizures due to hyperoxia - Fire or explosion hazard when used near open flames - Pulmonary edema in susceptible patients

Keol-C should be used under medical supervision with appropriate monitoring.

Assess oxygen saturation before initiating therapy: ensure the patient requires supplemental oxygen. Adjust flow rate per prescription: follow the clinician‑specified flow‑meter settings. Monitor for signs of hypercapnia in COPD patients: watch for worsening CO2 retention. Avoid use in patients with known oxygen hypersensitivity: discontinue if adverse reaction occurs. Use with caution around smokers or open flames: fire risk is increased with high‑concentration oxygen. Store at ambient temperature: keep cylinders upright, protected from heat, direct sunlight and secure to prevent falling.

Keol-C may interact with certain therapies and medications.

Major Interactions (Avoid): - Nitric oxide therapy: concurrent use can reduce the effectiveness of both gases. - Bleomycin or other pulmonary‑toxic agents: increased risk of lung injury. - Hyperbaric oxygen treatment: excessive oxygen exposure can cause toxicity.

Moderate Interactions (Monitor Closely): - Sedatives or opioids: may depress respiratory drive, requiring closer monitoring. - Bronchodilators: may enhance oxygen uptake, adjust flow as needed. - Corticosteroids: monitor for potential changes in infection risk while on high‑flow oxygen.